跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 5,408 条关于
“WEE1 kinase”
全部
5,408
临床试验
3,111
药物
460
机构
16
资讯
1,821
去年
FDA Clears IND for MRANK-106, First-in-Class Dual WEE1/YES1 Kinase Inhibitor for Advanced Solid Tumors
上个月
Aprea Therapeutics Expands Global Patent Portfolio for WEE1 and ATR Precision Oncology Programs
去年
Aprea Therapeutics Advances APR-1051 Clinical Trial with First HPV+ Head and Neck Cancer Patient Dosed
10个月前
Aprea Therapeutics Reports Promising Early Clinical Data for DNA Damage Response Inhibitors
去年
First Patient Dosed in Novel Breast Cancer Trial Combining WEE1 Inhibitor with Trodelvy
9个月前
Aprea Therapeutics Secures $3.1 Million Private Placement to Advance Cancer-Targeting Drug Development
3个月前
Nuvation Bio Director Buys 25,000 Shares as Taletrectinib Gains Global Regulatory Momentum
7个月前
Aprea Therapeutics Appoints Eugene Kennedy as Chief Medical Advisor Following Early Clinical Success with WEE1 Inhibitor
去年
Aprea Therapeutics Optimizes ATRN-119 Dosing in Phase 1/2a Trial for Advanced Solid Tumors
2年前
FDA Lifts Partial Clinical Hold on Azenosertib Trials in Advanced Solid Tumors
第 1 页,共 183 页
上一页
下一页